MAQC Society Webinar series

Join event
Date & Time 16 February - 20 April 2021 at 17.00 CET
Address Virtual

We are happy to share information on the new MAQC-society Webinar Series. These presentations are from science and bioinformatic leaders as they discuss findings and results in cancer genomics and related areas: variant detection of all types (SNVs, Indels, structural variants, CNVs and CNAs), information on new reference materials to test and validate bioinformatic processes, including matched tumor-normal pairs and admixtures of cell lines, evaluation and comparison of cancer panels and liquid biopsy assays, reproducible scRNA-seq methods, and other exciting areas such as epigenomics. These presentations are associated with new research currently being published in Nature Biotechnology, Genome Biology, Cell Genomics, and other journals.

The first four webinars are free to all (after that for MAQC Society members only) and begin on Tuesday 16 February 2021 and will go every Tuesday from 16 February to 20 April 2021 at 17.00 CET leading up to the 4th annual meeting of the MAQC Society (26-28 April 2021).

You can register for the webinars here and see more information here.

Sessions

  • 16 February
    A MAQC/SEQC Journey Towards Reproducible Genomics and the MAQC Society
    Weida Tong, PhD
    President, MCBIOS, and Director, Division of Bioinformatics and Biostatistics, FDA-NCTR
    Wendell Jones, PhD
    Executive Chair and President, MAQC Society, and Principle Bioinformaticist and Scientific Advisor, Q2 Solutions / EA Genomics

 

  • 23 February
    Towards best practice in cancer mutation detection with whole-genome and whole-exome sequencing
    Dr. Wenming Xiao
    Senior Scientific Reviewer, Division of Molecular Genetics and Pathology, FDA-OIR

 

  • 2 March
    Establishing reference data and call sets for benchmarking cancer mutation detection using whole-genome sequencing
    Li Tai Fang, PhD
    Staff Scientist, Endpoint Health, Inc.

 

  • 9 March
    A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples
    Charles Wang, MD, PhD, MPH
    Professor and Director of Center for Genomics, Loma Linda University School of Medicine

 

  • 16 March
    Critical Assessment of Copy Number Variation Calling Using Next Generation Sequencing
    Mehdi Pirooznia , MD, MSc, PhD
    Director of Bioinformatics and Computational Biology Core, NHLBI

 

  • 23 March
    A Verified Genomic Reference Sample for Assessing Performance of Cancer Panels Detecting Small Variants of Low Allele Frequency
    Wendell Jones, PhD
    Principal Bioinformaticist and Scientific Advisor, Q2 Solutions / EA Genomics
    Executive Chair and President, MAQC Society

 

  • 30 March
    Multi-lab cross-oncopanel study reveals high sensitivity and reproducibility tailored to targeted regions and allele frequency ranges
    Binsheng Gong, PhD
    Staff Fellow, Division of Bioinformatics and Biostatistics, FDA-NCTR

 

  • 6 April
    Evaluating the analytical validity of circulating tumor DNA sequencing for precision oncology
    Joshua Xu, PhD
    Branch Chief for Research-to-Review — Division of Bioinformatics and Biostatistics, FDA-NCTR
    Executive Secretary, MAQC Society

 

  • 7 April
    Robust Cancer Mutation Detection with Deep Learning Models Derived from Tumor-Normal Sequencing Data
    Mohammad Sahraeian, PhD
    Senior Bioinformatics Scientist, Roche Sequencing Solutions

 

  • 13 April
    The Epigenome Quality Control (EpiQC) Project
    Christopher Mason, PhD
    Associate Professor; Director, WorldQuant Initiative for Quantitative Prediction Physiology and Biophysics/Feil Family Brain and Mind Institute/Institute for Computational Biomedicine, Weill Cornell Medicine

 

  • 14 April
    Multi-Platform Assessment of DNA Sequencing Performance using Human and Bacterial Reference Genomes in the ABRF Next-Generation Sequencing Study
    Jonathan Foox, PhD
    Research Associate in Computational Biomedicine, Weill Cornell Medicine

 

  • 20 April
    Assessing Reproducibility of Germline Variants Detected with Short-read Whole Genome Sequencing
    Huixiao Hong, PhD
    Chief, Bioinformatics Branch, FDA-NCTR

Share

Like what you read? Share your thoughts!